Literature DB >> 6121870

Determination of biological activity of alprazolam, triazolam and their metabolites.

V H Sethy, D W Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121870     DOI: 10.1111/j.2042-7158.1982.tb04197.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  17 in total

Review 1.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 2.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

3.  Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.

Authors:  R Jochemsen; J G Wesselman; C J van Boxtel; J Hermans; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects.

Authors:  R B Smith; P D Kroboth
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

Review 6.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

7.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

8.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 9.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

10.  N-desmethyladinazolam pharmacokinetics and behavioral effects following administration of 10-50 mg oral doses in healthy volunteers.

Authors:  J C Fleishaker; T C Smith; H Friedman; J P Phillips
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.